cgp 37157 has been researched along with Bone Cancer in 1 studies
CGP 37157: benzothiazepine derivative of clonazepam; inhibits the in vitro activity of mitochondrial sodium-calcium exchange
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ohshima, Y | 1 |
| Takata, N | 1 |
| Suzuki-Karasaki, M | 1 |
| Yoshida, Y | 1 |
| Tokuhashi, Y | 1 |
| Suzuki-Karasaki, Y | 1 |
1 other study available for cgp 37157 and Bone Cancer
| Article | Year |
|---|---|
Disrupting mitochondrial Ca2+ homeostasis causes tumor-selective TRAIL sensitization through mitochondrial network abnormalities.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Calcium; Cell Line, Tumor; Clonazepa | 2017 |